BRNZ Concept Document
Product Concept · 2025

AI Clinical
Reimbursement
System

A self-optimizing intelligence platform that eliminates the $300B+ administrative waste in healthcare claims processing — turning an adversarial system into a collaborative one.

$344B
Global RCM Market
Grand View Research, 2024
~20%
Claims Denied
First submission denial rate
30-90
Days to Process
Average claim lifecycle
<3s
Our Target
Claim adjudication time
Scroll
01

Executive Summary

The Opportunity

Healthcare reimbursement is the financial backbone of a $4.5 trillion industry (CMS National Health Expenditure, 2023), yet it runs on processes designed in the 1990s. The global Revenue Cycle Management market reached $344 billion in 2024 (Grand View Research) — a market built almost entirely on patching a broken system rather than replacing it.

We propose the first self-optimizing AI clinical reimbursement platform — a system that doesn't just automate claims processing but learns from every decision, becoming more accurate with every claim it touches. This is the compound intelligence play: the same BRNZ DNA that powers KENSAI in cybersecurity, applied to the $344B healthcare admin market.

Auto-Code & Validate
Map clinical documentation to ICD-10/CPT codes with >99% accuracy. Pre-validate every claim before submission.
Instant Adjudication
AI reviews and decides claims in seconds. Reduce the 30-90 day cycle to near-real-time.
Self-Optimizing (BRNZ DNA)
Every claim processed teaches the system. Compound intelligence builds an insurmountable data moat.
02

The $300B Problem

The US healthcare system spends more on administration than it does on heart disease and cancer care combined. Here's where the money goes.

$265B
Billing & Insurance-Related Costs

Administrative complexity of multi-payer billing, eligibility verification, claims submission, and payment posting. The JAMA study (Tseng et al., 2018) estimated BIR costs at ~$265.6B annually.

Source: JAMA, 2018
$100B+
Healthcare Fraud

The National Health Care Anti-Fraud Association (NHCAA) estimates fraud accounts for 3-10% of total health spending. At $4.5T total, that's $135-450B. FBI estimates conservatively at $100B+.

Source: NHCAA / FBI
$40-80
Cost Per Claim (Provider)

Each claim costs providers $40-80 in administrative labor — coding, submission, follow-up, appeals. With billions of claims annually, this is a trillion-dollar friction layer.

Source: MGMA / CAQH Index
~17%
Initial Denial Rate

According to Change Healthcare's 2024 Revenue Cycle Denials Index, the average initial denial rate is approximately 17%. Some specialties see 20%+ denial rates on first submission.

Source: Change Healthcare, 2024
72,750+
ICD-10-CM Codes

The ICD-10-CM code set contains over 72,750 diagnosis codes. Add ICD-10-PCS (87,000+ procedure codes), CPT (10,000+), and HCPCS — and you have a coding nightmare for humans.

Source: CMS / WHO
34%
Admin Share of Health Spending

The US spends approximately 34% of total healthcare expenditure on administration — the highest of any OECD country. Canada spends 17%. The gap is the multi-payer complexity tax.

Source: Annals of Internal Medicine

The Human Cost

Patients
  • Treatment delays from prior auth — 94% of physicians report care delays (AMA, 2023)
  • Surprise bills from denied claims patients thought were covered
  • Patients forgo care entirely due to uncertainty about coverage
Providers
  • Physicians spend 15+ hours/week on prior auth paperwork (AMA survey)
  • Small practices hire 1 FTE per 2 physicians just for billing
  • Revenue leakage from undercoding — estimated 5-10% of billable revenue
Insurers
  • Major payers employ 10,000+ claims processors each
  • Fraud costs exceed $100B/year, requiring massive SIU departments
  • Regulatory penalties for improper denials (CMS enforcement growing)

The Core Dysfunction: An Adversarial System

The current reimbursement system is fundamentally adversarial. Providers are incentivized to upcode (bill more); insurers are incentivized to deny (pay less). Both sides employ armies of specialists to fight each other. This is a zero-sum game that patients lose. Our system replaces adversarial dynamics with transparent, evidence-based decisioning that both sides can trust.

03

Product Architecture

End-to-end intelligence from clinical encounter to payment. Every step is AI-augmented, every decision is explainable, every outcome feeds back into the system.

Step 1
Clinical Documentation

EHR data ingestion via FHIR R4/HL7v2. Clinical notes, lab results, imaging reports, medication orders.

Step 2
AI Auto-Coding

Clinical NLP extracts diagnoses & procedures. Maps to ICD-10-CM, CPT, HCPCS. Suggests modifiers. Confidence scoring.

Step 3
Pre-Validation

Medical necessity check, bundling rules, modifier logic, coverage verification, duplicate detection. Fix before submit.

Step 4
AI Adjudication

Policy rules engine + medical necessity AI. Real-time benefit verification. Fraud detection. Explainable decisions.

Step 5
Payment & Feedback

Auto-payment, ERA posting, patient responsibility calc. Every outcome feeds the self-optimization loop.

Self-Optimization Loop — Every decision trains the model
Today's Process
Manual coding by certified coders — $50K-70K salary each
Claims bounce between provider and payer 3-5 times average
Prior auth takes 1-14 business days per request
Appeals take 30-60 days, success rate ~50%
Same mistakes repeated — system never learns
With Our System
AI auto-codes in <2 seconds with >99% accuracy target
Pre-validation catches 95%+ of denial-causing errors
Prior auth generated and submitted in <60 seconds
AI-generated appeals with evidence — predicted overturn rate
Every decision feeds back — system gets smarter daily
04

Core AI Modules

Eight interconnected AI modules, each specialized but sharing a common intelligence layer. Together they form a closed-loop system that improves with every claim.

MODULE A

Clinical NLP Engine

Reads unstructured clinical notes, discharge summaries, operative reports, pathology results, and radiology impressions. Extracts structured clinical concepts: diagnoses, procedures performed, medications prescribed, lab values, and clinical reasoning.

Input Example
"Pt presents with acute exacerbation of COPD with hypoxic respiratory failure. CXR shows bilateral infiltrates c/w pneumonia. Started on BiPAP, IV abx (ceftriaxone + azithromycin), systemic steroids."
Extracted Entities
Dx: COPD exacerbation (J44.1), Pneumonia (J18.9), Hypoxic resp failure (J96.01)
Proc: BiPAP (94660), CXR (71046)
Rx: Ceftriaxone, Azithromycin, Steroids
MODULE B

Auto-Coder

Maps extracted clinical concepts to the correct billing codes across four code systems: ICD-10-CM (72,750+ diagnosis codes), ICD-10-PCS (87,000+ inpatient procedure codes), CPT (10,000+ outpatient procedure codes), and HCPCS Level II (7,000+ supply/service codes). Handles modifier selection (25, 59, 76, etc.), laterality, specificity level, and sequencing rules.

ICD-10-CM ICD-10-PCS CPT HCPCS L2 Modifiers DRG Assignment
Coding Example
Primary Dx: J44.1 — COPD with acute exacerbation
Secondary: J18.9 — Pneumonia, unspecified
Secondary: J96.01 — Acute resp failure, hypoxic
CPT: 99223 — Initial hospital care, high complexity
CPT: 94660 — CPAP/BiPAP initiation
CPT: 71046 — Chest X-ray, 2 views
Confidence: 97.3% | Flag: Review J18.9 specificity
MODULE C

Pre-Validation Engine

The denial prevention layer. Before any claim is submitted, this module runs 200+ validation checks: medical necessity against payer-specific LCD/NCD policies, NCCI bundling edits, modifier appropriateness, timely filing limits, duplicate claim detection, patient eligibility/benefit verification, and place-of-service rules. Goal: reduce first-pass denial rate from ~17% to <2%.

200+
Validation rules
<2%
Target denial rate
<500ms
Validation time
MODULE D

Adjudication AI

The insurer-side brain. Applies payer-specific policy rules, medical necessity criteria (InterQual/MCG equivalent), benefit plan verification, coordination of benefits, and payment calculation (fee schedule, allowed amounts, deductible/coinsurance application). Every decision includes an explainability layer with specific policy citations — critical for regulatory compliance and provider trust.

Decision Output
Claim: 2025-CLM-847291 | Status: APPROVED
Allowed: $4,287.00 | Patient resp: $428.70 (10% coinsurance)
Reason: Medical necessity met per LCD L35062 (COPD acute exacerbation criteria). BiPAP documented as medically necessary per O2 sat <88% on arrival. Chest X-ray appropriate for pneumonia workup.
Confidence: 99.1% | Processing time: 1.8s
MODULE E

Fraud Detection

Multi-layered fraud detection combining anomaly detection (statistical deviation from peer benchmarks), network analysis (identifying collusion rings between providers, patients, and facilities), temporal pattern analysis (impossible billing patterns like 26-hour days), and clinical plausibility scoring (does the treatment match the diagnosis?). Estimated to catch $3-5 in fraud for every $1 spent on detection.

Anomaly Detection Network Graph Analysis Temporal Patterns Clinical Plausibility Upcoding Detection Phantom Billing
MODULE F

Prior Auth Bot

Automatically generates prior authorization requests by extracting clinical justification from the medical record, mapping to payer-specific criteria, and predicting approval probability. If probability is <70%, suggests additional documentation or alternative treatments. Integrates with emerging CMS Interoperability rules (CMS-0057-F) mandating electronic prior auth by January 2027.

MODULE G

Appeals Engine

When claims are denied, this module analyzes the denial reason, pulls supporting clinical evidence from the medical record, identifies relevant clinical guidelines (AMA, specialty societies), and generates a structured appeal letter with evidence citations. Predicts overturn probability based on payer, denial reason, and historical patterns. Average appeal success rate target: 70%+ (vs industry average of ~50%).

MODULE H — THE BRNZ DIFFERENTIATOR

Self-Optimization Loop

The compound intelligence layer. Every claim outcome — approved, denied, appealed, overturned — feeds back into every other module. The auto-coder learns which codes get denied by specific payers. The pre-validator learns new denial patterns before they're documented. The fraud detector refines its anomaly thresholds. The appeals engine learns which arguments succeed.

This is the moat. After processing 1M claims, the system is categorically different from one that processed 100K. After 10M claims, it's untouchable. Same principle as KENSAI — self-optimizing pipelines via DSPy that get better with scale.

05

Technology Stack

Purpose-built for healthcare AI. Every technology choice serves accuracy, explainability, compliance, and self-optimization.

Clinical NLP & LLMs

  • Fine-tuned medical LLMs (e.g., based on Llama 3 / Mixtral) trained on MIMIC-IV, clinical notes corpora
  • BiomedBERT / ClinicalBERT for entity extraction and relation mapping
  • DSPy for self-optimizing prompt pipelines — the BRNZ DNA
  • Retrieval-augmented generation (RAG) over payer policies, CMS guidelines, clinical criteria

Medical Knowledge Graph

  • SNOMED CT — 350,000+ clinical concepts with hierarchical relationships
  • UMLS Metathesaurus for cross-ontology mapping (ICD-10 ↔ SNOMED ↔ CPT)
  • RxNorm for medication normalization and drug interaction data
  • Neo4j/TigerGraph for graph-based traversal and fraud network analysis

Data & Integration

  • FHIR R4 / HL7v2 for EHR integration (Epic, Cerner, Athenahealth)
  • X12 EDI (837/835/276/277) for claims transmission
  • Apache Kafka / Flink for real-time claim streaming at scale
  • PostgreSQL + TimescaleDB for transactional + time-series data

Explainability & Compliance

  • SHAP / LIME for model interpretability on every claim decision
  • Audit trail with immutable logging (every decision traceable)
  • HITRUST / SOC 2 Type II compliant infrastructure
  • Zero-trust architecture, end-to-end encryption, PHI segmentation
06

Competitive Landscape

The RCM market is massive but fragmented. No player offers true end-to-end AI with self-optimization. Most are workflow tools with rule-based automation bolted on.

Company Valuation / Revenue Focus AI Depth Self-Optimizing?
Change Healthcare (Optum) Acquired by UHG for $13B (2022) Full RCM, clearinghouse, analytics Medium — Rules + basic ML No
Waystar IPO 2024, ~$3.7B valuation RCM platform, payment management Medium — Predictive analytics No
Availity ~$1.5B (est.) Payer-provider data exchange Low — Workflow automation No
Olive AI Raised $848M, collapsed 2023-24 Healthcare RPA / AI automation Medium — RPA + ML No — Failed
Aidoc $250M+ raised, $1.3B valuation Radiology AI triage High — Deep learning Partial — Clinical only
Viz.ai $250M+ raised, $1.2B valuation Clinical AI coordination High — Deep learning Partial — Clinical only
R1 RCM (Acclara) Taken private for $8.9B (2024) End-to-end RCM outsourcing Medium — Analytics + labor No
BRNZ (Ours) Pre-revenue / Concept End-to-end AI reimbursement Highest — LLM + DSPy Yes — Core DNA

Why No Competitor Is Self-Optimizing

Rule-based systems (Change Healthcare, Waystar, R1) encode human knowledge as static rules. When CMS updates a policy, a human must update the rules. They don't learn from outcomes — they only do what they're told.

Olive AI's failure ($848M raised, collapsed) is instructive: they tried to automate healthcare workflows with RPA (robotic process automation), which is fundamentally brittle. Screen-scraping and click-automation breaks when UIs change. Real AI requires understanding clinical semantics, not clicking buttons.

Clinical AI companies (Aidoc, Viz.ai) build excellent deep learning for specific clinical use cases (radiology, stroke detection) but don't touch the reimbursement pipeline. They're clinical tools, not financial infrastructure.

Our approach is fundamentally different: DSPy-powered self-optimizing pipelines that treat every claim decision as a training signal. This is the same compound intelligence architecture that makes KENSAI's security scanning improve with every scan. No competitor has this DNA.

07

Market Opportunity

Multiple overlapping markets, each massive in its own right. The convergence of AI capability and regulatory mandate creates a once-in-a-generation window.

$344B
Global RCM Market (2024)

Revenue Cycle Management encompasses claims processing, billing, collections, and payment management across all healthcare settings.

Source: Grand View Research, 2024
$4.5T
US National Health Expenditure (2023)

Total US healthcare spending, of which ~34% ($1.5T+) goes to administrative functions. Every dollar of admin spending is addressable.

Source: CMS NHE Data
$78B
US Healthcare IT Market (2024)

Healthcare IT including EHR, RCM, analytics, telehealth, and clinical systems. Growing at ~15% CAGR driven by AI adoption and regulatory mandates.

Source: Fortune Business Insights (est.)
$4.2B
Prior Authorization Automation (2024)

CMS mandated electronic prior auth by January 2027. This creates forced adoption of automation tools across all Medicare Advantage and Medicaid plans.

Source: Market estimates, CMS-0057-F rule
$10B+
Medical Coding Market

Professional medical coding services, outsourcing, and coding software. Chronic shortage of certified coders (AAPC estimates 30% shortage) drives AI adoption.

Source: AAPC / Industry estimates
$100B+
Healthcare Fraud (Addressable)

FBI estimates $100B+ in annual healthcare fraud. AI fraud detection saves $3-5 per dollar invested. This alone justifies the platform for insurers.

Source: FBI / NHCAA

Regulatory Tailwinds

CMS Interoperability Rule (CMS-0057-F)

Mandates electronic prior authorization for Medicare Advantage and Medicaid managed care plans by January 1, 2027. Payers must respond within 72 hours for urgent requests, 7 days for standard. This creates forced adoption of automated prior auth systems.

No Surprises Act (2022)

Requires price transparency and prohibits surprise billing. Creates demand for real-time eligibility/benefit verification and accurate cost estimation — both core capabilities of our platform.

ICD-10 Annual Updates

CMS adds ~1,000-2,000 new ICD-10 codes annually. Each update creates coding errors and denials. Self-optimizing systems handle updates automatically; rule-based systems require manual reconfiguration.

EU: European Health Data Space (EHDS)

The EHDS regulation (proposed 2022, expected adoption 2025) creates a framework for health data interoperability across EU member states — opening the door for AI reimbursement platforms in a $2T+ European healthcare market.

08

The Self-Optimizing Moat

BRNZ DNA — The compound intelligence play that makes every claim processed a permanent competitive advantage.

This is not incremental automation. This is a system that gets categorically better with scale, creating an exponential moat that no amount of engineering can replicate without the data.

The Compound Intelligence Flywheel
Process Claims
Each claim generates labeled training data
Learn Patterns
DSPy optimizes prompts and model weights
Improve Accuracy
Denial rate drops, fraud catch rate rises
Win More Customers
Better results attract more volume
Repeat — The flywheel accelerates with every cycle

What the System Learns

01 Payer-specific denial patterns — Aetna denies code X for reason Y at rate Z%, but approves with modifier 25
02 Regional coding variations — E/M documentation requirements differ between MACs (Medicare Administrative Contractors)
03 Seasonal claim patterns — flu-related claims spike in Q1, leading to specific denial patterns
04 Appeal success predictors — which clinical evidence and arguments win appeals for each payer
05 Fraud signatures — new fraud patterns detected automatically, not waiting for OIG reports

Scale = Moat

100K claims processed Baseline accuracy
1M claims processed Payer-specific optimization
10M claims processed Regional + specialty patterns
100M claims processed Untouchable — compound intelligence

Like KENSAI in security: the more scans you run, the smarter the system becomes. A competitor starting from zero can't buy this data advantage.

09

Compliance & Ethics

Healthcare AI that makes financial decisions about patient care is the highest-stakes AI application outside of autonomous weapons. We take this seriously.

HIPAA Compliance

  • All PHI encrypted at rest (AES-256) and in transit (TLS 1.3)
  • BAA (Business Associate Agreement) with every customer
  • Role-based access controls with minimum necessary standard
  • Complete audit trail — every data access logged and retained 6 years
  • HITRUST CSF certification target within 12 months

EU Health Data Regulations

  • GDPR Article 9 — special category data (health) processing safeguards
  • European Health Data Space (EHDS) readiness for cross-border interoperability
  • EU AI Act compliance — healthcare AI classified as high-risk (Annex III)
  • Data residency controls — EU data stays in EU
  • Right to human review for any AI-made coverage decision

Explainability — Non-Negotiable

Every decision must be explainable to three audiences:

For Providers

"Your claim was denied because the documentation did not meet LCD L35062 criteria. Specifically, O2 saturation was not documented. Adding this would likely result in approval."

For Patients

"Your insurer reviewed your claim and found that the treatment is covered. Your share is $428.70 based on your 10% coinsurance. You have the right to appeal any decision."

For Regulators

"Decision made using model v3.2.1, trained on 2.4M claims. SHAP values: diagnosis code (0.34), procedure alignment (0.28), policy match (0.22). Full audit trail available."

10

Revenue Model

Multiple revenue streams, each aligned with customer value.

Primary Revenue

Per-Claim Processing Fee

Auto-coding only $1.50 - $3.00 / claim
Coding + Pre-validation $3.00 - $6.00 / claim
Full pipeline (incl. prior auth) $5.00 - $12.00 / claim
Adjudication (insurer side) $2.00 - $8.00 / claim

Compared to $40-80/claim in current admin costs, even $12/claim represents 75-85% savings.

Secondary Revenue

SaaS + Performance

Platform Subscription

$2,000-$25,000/month based on practice size. Includes dashboard, analytics, reporting.

Revenue Share on Recovered Denials

15-25% of recovered revenue from successful appeals. Typical recovery: $50K-500K/year per mid-size practice.

Enterprise Licensing

Health systems and large payers: $500K-$5M annual license for on-premise or private cloud.

Unit Economics (Illustrative)

$8
Avg revenue/claim
$0.50
Compute cost/claim
94%
Gross margin (est.)
$80M
ARR at 10M claims/yr
11

Go-to-Market Strategy

Start narrow, prove accuracy, expand with data advantage.

1

Beachhead: Mid-Size Provider Groups 100-500 physicians

Multi-specialty groups that feel the pain most. Large enough for volume (10K-50K claims/month), small enough to decide fast.

Target: 10-20 pilots in year 1 · ~$2-5M ARR
2

Expand: Health Systems & Hospitals 500-5,000 beds

Proven accuracy from Phase 1 becomes the sales weapon. Health systems process 100K-1M+ claims/month. Inpatient DRG coding is highest-value.

Target: 20-50 health systems · $15-40M ARR
3

Cross the Aisle: Sell to Insurers Payer-side AI

The game-changing move. Once processing for providers, we have data to offer AI adjudication to insurers. Payers save billions.

Target: 5-10 mid-size payers · $50-100M ARR
4

Endgame: The Neutral Infrastructure Layer Platform play

Both sides use our AI. We become the intelligent clearinghouse — a neutral, trusted layer replacing adversarial dynamics. Think Visa for healthcare payments, but with AI intelligence.

Target: Market infrastructure position · $500M+ ARR potential
12

Implementation Roadmap

Aggressive but achievable. Each phase delivers standalone value.

PHASE 1 · MONTHS 1-3

Auto-Coding + Pre-Validation MVP

  • ▸ Clinical NLP engine (Module A)
  • ▸ ICD-10-CM auto-coding (Module B, partial)
  • ▸ CPT auto-coding for top 50 specialties
  • ▸ Basic pre-validation (NCCI edits, bundling)
  • ▸ FHIR R4 integration with 3 EHR platforms
  • ▸ DSPy self-optimization pipeline v1
  • ▸ HIPAA-compliant infrastructure
  • ▸ 3-5 pilot customers, 10K claims processed
PHASE 2 · MONTHS 4-6

Prior Auth + Appeals Automation

  • ▸ Prior Auth Bot (Module F)
  • ▸ Appeals Engine (Module G)
  • ▸ Full pre-validation with payer-specific rules
  • ▸ Revenue share model launch
  • ▸ Integration with top 5 clearinghouses
  • ▸ Approval prediction model
  • ▸ 15-20 customers, 100K claims processed
  • ▸ Self-optimization showing measurable improvement
PHASE 3 · MONTHS 7-12

Adjudication AI + Fraud Detection

  • ▸ Adjudication AI (Module D) for payers
  • ▸ Fraud Detection (Module E)
  • ▸ Explainability layer (SHAP/LIME)
  • ▸ First payer pilot
  • ▸ DRG assignment for inpatient coding
  • ▸ Knowledge graph v2 (SNOMED + RxNorm)
  • ▸ 50+ customers, 1M claims processed
  • ▸ HITRUST CSF certification
PHASE 4 · YEAR 2

Full Ecosystem — The Intelligent Clearinghouse

  • ▸ Both-side platform (providers + payers)
  • ▸ Real-time eligibility + benefit verification
  • ▸ Patient cost estimation
  • ▸ EU market expansion (EHDS compliance)
  • ▸ API marketplace for third-party integrations
  • ▸ 10M+ claims processed, compound intelligence moat
  • ▸ SOC 2 Type II certification
  • ▸ Series A / growth funding
The Bottom Line

Healthcare reimbursement is a $344B market running on 1990s technology.
The first self-optimizing AI wins it.

This isn't about making claims processing 10% faster. It's about replacing the adversarial, error-prone, fraud-riddled infrastructure with transparent AI that gets smarter with every claim. The compound intelligence moat makes the first mover the permanent winner.